Skip to main content
Industry News
Study shows efficacy of insulin-and-pramlintide artificial pancreas

A study published in Diabetes Care shows that a novel rapid insulin-and-pramlintide artificial pancreas system is better in controlling glucose level than a rapid insulin-alone artificial pancreas, without increasing hypoglycemia risk, in adults with type 1 diabetes. The novel dual-hormone artificial pancreas system showed an increased time in target range and reduced mean glucose level, glucose coefficient of variance and glucose standard deviation during daytime hours, compared with a rapid insulin-alone artificial pancreas.

Full Story: